Breast and prostate cancers harbor common somatic copy number alterations that consistently differ by race and are associated with survival
Yalei Chen(Pfizer (United States)), Albert M. Levin(Henry Ford Hospital), Kanika Taneja(Henry Ford Health System), Craig Rogers(Norfolk and Norwich University Hospitals NHS Foundation Trust), Lisa A. Newman(Cornell University), Jia Li(Zhejiang Chinese Medical University), Dhananjay Chitale(Henry Ford Hospital), Melissa B. Davis(Cornell University), Sudha M. Sadasivan(Henry Ford Health System), Benjamin A. Rybicki(Henry Ford Health System), Nilesh Gupta(Henry Ford Health System), Pamela L. Paris(University of California, San Francisco), Ruicong She(Henry Ford Health System), Indrani Datta(Henry Ford Health System)
Cited by 26
Related Papers
Breast Cancer Statistics, 2022
|CA A Cancer Journal for Clinicians|2022|2.4k
Breast cancer statistics 2024
|CA A Cancer Journal for Clinicians|2024|661
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219